[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"app-context":3,"blog-johnson-johnson-jumps-4-4-as-varipulse-pro-hits-100-procedural-success-KO":150},{"languages":4,"categories":41,"products":125,"competitors":149},[5,9,13,17,21,25,29,33,37],{"name":6,"code":7,"id":8},"English","EN","TGFuZ3VhZ2U6ZW4=",{"name":10,"code":11,"id":12},"Español","ES","TGFuZ3VhZ2U6ZXM=",{"name":14,"code":15,"id":16},"Português","PT","TGFuZ3VhZ2U6cHQ=",{"name":18,"code":19,"id":20},"日本語","JA","TGFuZ3VhZ2U6amE=",{"name":22,"code":23,"id":24},"한국어","KO","TGFuZ3VhZ2U6a28=",{"name":26,"code":27,"id":28},"Deutsch","DE","TGFuZ3VhZ2U6ZGU=",{"name":30,"code":31,"id":32},"Italiano","IT","TGFuZ3VhZ2U6aXQ=",{"name":34,"code":35,"id":36},"Français","FR","TGFuZ3VhZ2U6ZnI=",{"name":38,"code":39,"id":40},"中文 (中国)","ZH","TGFuZ3VhZ2U6emg=",[42,73,104],{"icon":43,"slug":44,"title":45,"description":46,"featuredLinks":47},"mingcute:stock-line","stock-market-basics","Stock Market Basics","\u003Cp>Beginners' guides and practical tips for understanding stock market investing.\u003C\u002Fp>\n",[48,53,58,63,68],{"url":49,"title":50,"description":51,"ogImage":52},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fwhat-makes-stocks-go-up-and-down","What Makes Stocks Go Up and Down | TIKR.com","Understanding what makes stock prices go up and down can help investors better navigate investing. Click to learn more!","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FWhat-makes-stocks-go-up-and-down-banner\u002FWhat-makes-stocks-go-up-and-down-banner.jpg?_i=AA",{"url":54,"title":55,"description":56,"ogImage":57},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fdividend-yield-meaning-formula-example","Dividend Yield: Meaning, Formula, Example | Tikr.com Blog | TIKR.com","The dividend yield is a key metric for investors looking to gauge the income potential of their investments. It measures how much a company pays out in","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FDividend-yield\u002FDividend-yield.png?_i=AA",{"url":59,"title":60,"description":61,"ogImage":62},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fmarket-capitalization-definition-formula-and-why-it-matters","Market Capitalization: Definition, Formula, and Why It Matters | TIKR.com","Long-term investors often look at various valuation metrics when deciding whether to invest in a particular company. One helpful metric to evaluate is","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FMarket-Capitalization-Definition-Formula-and-Why-It-Matters\u002FMarket-Capitalization-Definition-Formula-and-Why-It-Matters.png?_i=AA",{"url":64,"title":65,"description":66,"ogImage":67},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fearnings-per-share-definition-formula-and-why-eps-matters","Earnings Per Share: Definition, Formula, and Why EPS Matters | TIKR.com","Earnings Per Share (EPS) represents the portion of a company's net earnings allocated to each share. Click to learn more!","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FEPS-Defiinition-formula-and-why-EPS-matters-1\u002FEPS-Defiinition-formula-and-why-EPS-matters-1.png?_i=AA",{"url":69,"title":70,"description":71,"ogImage":72},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fwhat-is-a-stock-price-target","What Is a Stock Price Target? | TIKR.com","A price target is a stock's estimated future price. It can help investors quickly find undervalued stocks. Learn more now!","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FWhat-is-a-Stock-Price-Target-2\u002FWhat-is-a-Stock-Price-Target-2.png?_i=AA",{"icon":74,"slug":75,"title":76,"description":77,"featuredLinks":78},"material-symbols:analytics-outline","fundamental-analysis","Fundamental Analysis","\u003Cp>In-depth resources and financial metrics to help you evaluate companies like a pro.\u003C\u002Fp>\n",[79,84,89,94,99],{"url":80,"title":81,"description":82,"ogImage":83},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fshare-repurchase-why-do-companies-buy-back-their-stock","Share Repurchase: Why Do Companies Buy Back Their Stock? | TIKR.com","Share repurchases, or share buybacks, have gained popularity in the last two decades. According to a report from Goldman Sachs, stock buybacks initiated","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FTIKR-BLOG-COVER-PHOTOS-3_544a7f4e\u002FTIKR-BLOG-COVER-PHOTOS-3_544a7f4e.png?_i=AA",{"url":85,"title":86,"description":87,"ogImage":88},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fwhat-is-a-good-return-on-invested-capital","What Is a Good Return on Invested Capital? | TIKR.com","Learning about Return on Invested Capital (ROIC) can help investors spot highly profitable stocks that can drive long-term returns. Learn more now!","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FWhat-is-a-good-return-on-Invested-capital\u002FWhat-is-a-good-return-on-Invested-capital.png?_i=AA",{"url":90,"title":91,"description":92,"ogImage":93},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fwhat-is-a-good-return-on-equity-ratio","What is a Good Return on Equity Ratio | Tikr.com Blog | TIKR.com","Return on Equity (ROE) is a financial ratio that reflects a company's profitability in relation to the equity invested by shareholders. It basically","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FWhat-is-a-good-return-on-equity-ratio-1\u002FWhat-is-a-good-return-on-equity-ratio-1.jpg?_i=AA",{"url":95,"title":96,"description":97,"ogImage":98},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fwhat-is-a-good-p-e-ratio","What Is a Good P\u002FE Ratio? | TIKR.com","Financial analysts and investors look at various metrics before deciding whether a stock is a buy. One of the metrics is the price-to-earnings ratio (P\u002FE","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FWhat-is-a-good-PE-ratio-1\u002FWhat-is-a-good-PE-ratio-1.jpg?_i=AA",{"url":100,"title":101,"description":102,"ogImage":103},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Ftop-6-metrics-for-investing-in-reits","Top 6 Metrics for Investing in REITs | TIKR.com","Real estate has been one of the greatest asset classes for wealth creation in history, and investing in Real Estate Investment Trusts (REITs) can allow","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FGroup-10\u002FGroup-10.png?_i=AA",{"icon":105,"slug":106,"title":107,"description":108,"featuredLinks":109},"hugeicons:investigation","investing-lingo","Investing Lingo","\u003Cp>A comprehensive glossary of investing terms and jargon so you can speak the language of the markets confidently.\u003C\u002Fp>\n",[110,115,120],{"url":111,"title":112,"description":113,"ogImage":114},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fenterprise-value-definition-and-calculation","Enterprise Value: Definition and Calculation | Tikr.com Blog | TIKR.com","Enterprise value (EV) is a financial metric that offers a comprehensive snapshot of a company's total value. Unlike market capitalization which solely","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FEnterprise-Value-Definition-and-Calculation_37576e40\u002FEnterprise-Value-Definition-and-Calculation_37576e40.png?_i=AA",{"url":116,"title":117,"description":118,"ogImage":119},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Febitda-definition-formula-how-to-use-it","EBITDA: Definition, Formula, How to Use It | TIKR.com","EBITDA stands for earnings before interest, taxes, depreciation and amortization. It's a financial metric commonly used to evaluate a company's financial","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FEBITDA-Definition-Formula-How-to-Use-It\u002FEBITDA-Definition-Formula-How-to-Use-It.png?_i=AA",{"url":121,"title":122,"description":123,"ogImage":124},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fwhat-is-the-free-cash-flow-formula-and-why-does-it-matter","What is the Free Cash Flow Formula and Why Does It Matter | TIKR.com","Free cash flow, or FCF, is the cash a company generates after it accounts for outflows required to maintain business operations and support capital","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FWhat-is-the-free-cash-flow-formula\u002FWhat-is-the-free-cash-flow-formula.png?_i=AA",[126,130,134,137,141,145],{"slug":127,"modified":128,"title":129},"valuation-model-builder","2025-07-03T00:18:53","Value Stocks Quickly and Accurately",{"slug":131,"modified":132,"title":133},"stock-portfolio-tracking","2024-12-02T22:21:28","Monitor Your Portfolio",{"slug":75,"modified":135,"title":136},"2025-01-21T22:10:52","Instantly Analyze Companies with In-Depth Metrics",{"slug":138,"modified":139,"title":140},"stock-screener","2024-12-02T22:13:31","Find the Best Stocks to Buy",{"slug":142,"modified":143,"title":144},"investor-stock-portfolio","2025-01-21T22:02:56","Follow Investment Moves of Top Investors",{"slug":146,"modified":147,"title":148},"analyze-stocks","2025-07-23T16:04:24","Analyze Stocks",[],{"post":151,"seo":187,"relatedPosts":195,"suggestedPosts":272},{"id":152,"title":153,"date":154,"modified":155,"excerpt":156,"content":157,"wordCount":158,"lang":159,"uri":160,"slug":161,"cloudinaryAssetId":162,"featuredImageOriginalUrl":163,"featuredImageMetadata":164,"author":167,"editor":173,"categories":178,"relatedPosts":184,"seo":185},143738,"Johnson & Johnson, 4.4% 급등… VARIPULSE Pro, 시술 성공률 100% 기록","2026-10-23T13:40:00","2026-10-22T20:06:04","\u003Cp>Johnson & Johnson이 4.4% 급등하며 실적 발표 후 하락분을 회복했는데, 이는 VARIPULSE Pro 데이터가 메드테크 부문에 드문 호재를 안겨주면서다.\u003C\u002Fp>","\u003Ch3 id=\"h-key-takeaways\" class=\"wp-block-heading\">주요 요점\u003C\u002Fh3>\n\n\n\n\u003Cul class=\"wp-block-list\">\n\u003Cli>존슨앤드존슨은 10월 22일 4.4% 상승해 $269에 거래되며, 3분기 메드테크 실적 부진으로 인한 당일 최대 6.9% 하락에서 회복했습니다.\u003C\u002Fli>\n\n\n\n\u003Cli>메드테크 매출은 2.5% 증가에 그쳐 $86억 달러를 기록한 반면, 혁신 의약품 부문은 Tremfya와 Caplyta 덕분에 7.7% 성장해 $167.6억 달러를 기록했습니다.\u003C\u002Fli>\n\n\n\n\u003Cli>VARIPULSE Pro는 225명의 심방세동 환자에서 100%의 급성 시술 성공률을 보였으나, 이 시스템은 아직 미국 승인을 받지 못했습니다.\u003C\u002Fli>\n\n\n\n\u003Cli>존슨앤드존슨은 아폴로와의 $200억 달러 매각 협상 보도 이후, 고관절 및 무릎 부문을 분사하는 쪽으로 기울고 있습니다.\u003C\u002Fli>\n\u003C\u002Ful>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">9일 전, \u003Cstrong>존슨앤드존슨 (\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fstock\u002Fabout?fid=1&ref=meufz8&cid=139677&tid=2623227\">JNJ\u003C\u002Fa>)\u003C\u002Fstrong>은 최대 6.9% 하락하며 2025년 4월 이후 가장 큰 일일 하락을 기록할 뻔했습니다. 목요일, 주가는 4.4% 상승해 $269에 거래되며, 매도세가 시작되기 전의 거래 가격보다 높아졌습니다.\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">이 움직임을 설명할 단일 헤드라인은 없습니다. 헬스케어 주식들은 투자자들이 기술 부채 우려로부터 안전자산을 찾으면서 상승했고, 존슨앤드존슨은 같은 날 VARIPULSE Pro 심장 절제 시스템에 대한 강력한 실제 데이터를 발표했습니다.\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">그럼에도 불구하고, 이 반등은 주가를 떨어뜨린 문제를 덮어버리고 있습니다. 메드테크는 3분기에 겨우 2.5% 성장했으며, 존슨앤드존슨은 이제 고관절 및 무릎 사업을 어떻게 처리할지 결정해야 합니다.\u003C\u002Fp>\n\n\n\n\u003Ch2 class=\"wp-block-heading\">의약품은 질주, 의료기기는 조깅\u003C\u002Fh2>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">분기 실적은 명확히 두 갈래로 나뉩니다:\u003C\u002Fp>\n\n\n\n\u003Cul class=\"wp-block-list\">\n\u003Cli>매출은 5.9% 증가해 $254억 달러를 기록했고, 조정 EPS $2.59는 $2.54의 예상을 상회했습니다.\u003C\u002Fli>\n\n\n\n\u003Cli>혁신 의약품 부문은 7.7% 성장해 $167.6억 달러를 기록했으며, Tremfya(68% 증가)와 Caplyta(66% 증가)가 주도했습니다.\u003C\u002Fli>\n\n\n\n\u003Cli>메드테크는 2.5% 증가해 $86억 달러를 기록했으며, $87.1억 달러 예상을 하회하며 두 분기 연속 실적 부진을 보였습니다.\u003C\u002Fli>\n\u003C\u002Ful>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">GAAP EPS는 주로 존슨앤드존슨의 제안된 탈크 분쟁 합의와 관련된 일회성 비용으로 인해 $0.09로 하락했습니다. 경영진은 여전히 2026년 예측을 중간값 기준 매출 약 $1,012억 달러, 조정 EPS $11.10 수준으로 약간 상향 조정했습니다.\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>미즈호 (\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fstock\u002Fabout?fid=1&ref=meufz8&cid=20759710&tid=22033710\">MFG\u003C\u002Fa>)\u003C\u002Fstrong> 애널리스트 Jared Holz는 고객 메모에서 의료기기 부진이 \"정말 전반적\"이라고 언급했습니다.\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">다음은 두 사업부를 나란히 비교한 것입니다.\u003C\u002Fp>\n\n\n\n\u003Cfigure class=\"wp-block-image size-full\">\u003Cimg width=\"3026\" height=\"2017\" data-public-id=\"images\u002FTIKR.com_JNJ-Johnson-Johnson-Innovative-Medicine-Operating-Revenue-and-MedTech-Operating-Revenue_1438466e789\u002FTIKR.com_JNJ-Johnson-Johnson-Innovative-Medicine-Operating-Revenue-and-MedTech-Operating-Revenue_1438466e789.webp\" loading=\"lazy\" decoding=\"async\" src=\"https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_3026,h_2017,c_scale\u002Ff_webp,q_auto\u002Fv1792699425\u002Fimages\u002FTIKR.com_JNJ-Johnson-Johnson-Innovative-Medicine-Operating-Revenue-and-MedTech-Operating-Revenue_1438466e789\u002FTIKR.com_JNJ-Johnson-Johnson-Innovative-Medicine-Operating-Revenue-and-MedTech-Operating-Revenue_1438466e789.webp?_i=AA\" alt=\"\" class=\"wp-post-143738 wp-image-143846\" data-format=\"webp\" data-transformations=\"f_webp,q_auto\" data-version=\"1792699425\" data-seo=\"1\" srcset=\"https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Ff_webp,q_auto\u002Fv1792699425\u002Fimages\u002FTIKR.com_JNJ-Johnson-Johnson-Innovative-Medicine-Operating-Revenue-and-MedTech-Operating-Revenue_1438466e789\u002FTIKR.com_JNJ-Johnson-Johnson-Innovative-Medicine-Operating-Revenue-and-MedTech-Operating-Revenue_1438466e789.webp?_i=AA 3026w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_1536,h_1024,c_scale\u002Ff_webp,q_auto\u002Fv1792699425\u002Fimages\u002FTIKR.com_JNJ-Johnson-Johnson-Innovative-Medicine-Operating-Revenue-and-MedTech-Operating-Revenue_1438466e789\u002FTIKR.com_JNJ-Johnson-Johnson-Innovative-Medicine-Operating-Revenue-and-MedTech-Operating-Revenue_1438466e789.webp?_i=AA 1536w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_767,h_511,c_scale\u002Ff_webp,q_auto\u002Fv1792699425\u002Fimages\u002FTIKR.com_JNJ-Johnson-Johnson-Innovative-Medicine-Operating-Revenue-and-MedTech-Operating-Revenue_1438466e789\u002FTIKR.com_JNJ-Johnson-Johnson-Innovative-Medicine-Operating-Revenue-and-MedTech-Operating-Revenue_1438466e789.webp?_i=AA 767w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_2048,h_1365,c_scale\u002Ff_webp,q_auto\u002Fv1792699425\u002Fimages\u002FTIKR.com_JNJ-Johnson-Johnson-Innovative-Medicine-Operating-Revenue-and-MedTech-Operating-Revenue_1438466e789\u002FTIKR.com_JNJ-Johnson-Johnson-Innovative-Medicine-Operating-Revenue-and-MedTech-Operating-Revenue_1438466e789.webp?_i=AA 2048w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1792699425\u002Fimages\u002FTIKR.com_JNJ-Johnson-Johnson-Innovative-Medicine-Operating-Revenue-and-MedTech-Operating-Revenue_1438466e789\u002FTIKR.com_JNJ-Johnson-Johnson-Innovative-Medicine-Operating-Revenue-and-MedTech-Operating-Revenue_1438466e789.webp?_i=AA 600w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_1199,h_799,c_scale\u002Ff_webp,q_auto\u002Fv1792699425\u002Fimages\u002FTIKR.com_JNJ-Johnson-Johnson-Innovative-Medicine-Operating-Revenue-and-MedTech-Operating-Revenue_1438466e789\u002FTIKR.com_JNJ-Johnson-Johnson-Innovative-Medicine-Operating-Revenue-and-MedTech-Operating-Revenue_1438466e789.webp?_i=AA 1199w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_1400,h_933,c_scale\u002Ff_webp,q_auto\u002Fv1792699425\u002Fimages\u002FTIKR.com_JNJ-Johnson-Johnson-Innovative-Medicine-Operating-Revenue-and-MedTech-Operating-Revenue_1438466e789\u002FTIKR.com_JNJ-Johnson-Johnson-Innovative-Medicine-Operating-Revenue-and-MedTech-Operating-Revenue_1438466e789.webp?_i=AA 1400w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_299,h_199,c_scale\u002Ff_webp,q_auto\u002Fv1792699425\u002Fimages\u002FTIKR.com_JNJ-Johnson-Johnson-Innovative-Medicine-Operating-Revenue-and-MedTech-Operating-Revenue_1438466e789\u002FTIKR.com_JNJ-Johnson-Johnson-Innovative-Medicine-Operating-Revenue-and-MedTech-Operating-Revenue_1438466e789.webp?_i=AA 299w\" sizes=\"auto, (max-width: 3026px) 100vw, 3026px\" \u002F>\u003Cfigcaption class=\"wp-element-caption\">존슨앤드존슨 (JNJ): 부문별 매출, 혁신 의약품 대 메드테크, 분기별, $10억 달러, 2024년 3분기–2026년 3분기 (\u003Cstrong>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\">TIKR\u003C\u002Fa>\u003C\u002Fstrong>)\u003C\u002Ffigcaption>\u003C\u002Ffigure>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">혁신 의약품 부문은 현재 매출의 약 3분의 2를 창출하며, 그 격차는 계속 벌어지고 있습니다.\u003C\u002Fp>\n\n\n\n\u003Ch2 class=\"wp-block-heading\">메드테크를 위한 심장 관련 도박\u003C\u002Fh2>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">존슨앤드존슨은 메드테크 성장 엔진이 필요하며, 전기생리학이 최고의 후보입니다.\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">새로운 VARIPULSE Pro 연구는 유럽 19개 센터의 225명의 심방세동 환자를 대상으로 했습니다. 100%의 급성 시술 성공률, 0.4%의 주요 부작용 발생률, 평균 절제 시간 17.9분을 기록했으며, 88.9%의 사례에서 단일 카테터가 사용되었습니다.\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">별도의 12개월 OMNYPULSE 데이터는 82.5%의 문서화된 부정맥 재발 없음을 보여주었습니다. VARIPULSE Pro는 유럽, 일본 및 아시아와 라틴 아메리카 일부 지역에서 판매되지만, 아직 미국 승인은 받지 못했습니다.\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">병원 예산은 점점 더 빡빡해지고 있습니다. \u003Cstrong>애보트 (\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fstock\u002Fabout?fid=1&ref=meufz8&cid=247483&tid=2586533\">ABT\u003C\u002Fa>)\u003C\u002Fstrong>는 방금 2026년 매출 성장 예측을 하향 조정했으며, CFO Joe Wolk은 인터뷰에서 걸프 국가들은 여전히 프리미엄 시스템을 원하지만 \"이제 그들의 예산은 국방 쪽으로 재배정되고 있다\"고 말했습니다.\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">존슨앤드존슨의 성장은 경쟁 의료기기 회사들과 비교했을 때 어떨까요?\u003C\u002Fp>\n\n\n\n\u003Cfigure class=\"wp-block-image size-full\">\u003Cimg width=\"3026\" height=\"2017\" data-public-id=\"images\u002FTIKR.com_JNJ-Johnson-Johnson-Total-Revenues-Change-YoY_143848db573\u002FTIKR.com_JNJ-Johnson-Johnson-Total-Revenues-Change-YoY_143848db573.webp\" loading=\"lazy\" decoding=\"async\" src=\"https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_3026,h_2017,c_scale\u002Ff_webp,q_auto\u002Fv1792699527\u002Fimages\u002FTIKR.com_JNJ-Johnson-Johnson-Total-Revenues-Change-YoY_143848db573\u002FTIKR.com_JNJ-Johnson-Johnson-Total-Revenues-Change-YoY_143848db573.webp?_i=AA\" alt=\"\" class=\"wp-post-143738 wp-image-143848\" data-format=\"webp\" data-transformations=\"f_webp,q_auto\" data-version=\"1792699527\" data-seo=\"1\" srcset=\"https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Ff_webp,q_auto\u002Fv1792699527\u002Fimages\u002FTIKR.com_JNJ-Johnson-Johnson-Total-Revenues-Change-YoY_143848db573\u002FTIKR.com_JNJ-Johnson-Johnson-Total-Revenues-Change-YoY_143848db573.webp?_i=AA 3026w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_767,h_511,c_scale\u002Ff_webp,q_auto\u002Fv1792699527\u002Fimages\u002FTIKR.com_JNJ-Johnson-Johnson-Total-Revenues-Change-YoY_143848db573\u002FTIKR.com_JNJ-Johnson-Johnson-Total-Revenues-Change-YoY_143848db573.webp?_i=AA 767w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_1536,h_1024,c_scale\u002Ff_webp,q_auto\u002Fv1792699527\u002Fimages\u002FTIKR.com_JNJ-Johnson-Johnson-Total-Revenues-Change-YoY_143848db573\u002FTIKR.com_JNJ-Johnson-Johnson-Total-Revenues-Change-YoY_143848db573.webp?_i=AA 1536w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1792699527\u002Fimages\u002FTIKR.com_JNJ-Johnson-Johnson-Total-Revenues-Change-YoY_143848db573\u002FTIKR.com_JNJ-Johnson-Johnson-Total-Revenues-Change-YoY_143848db573.webp?_i=AA 600w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_2048,h_1365,c_scale\u002Ff_webp,q_auto\u002Fv1792699527\u002Fimages\u002FTIKR.com_JNJ-Johnson-Johnson-Total-Revenues-Change-YoY_143848db573\u002FTIKR.com_JNJ-Johnson-Johnson-Total-Revenues-Change-YoY_143848db573.webp?_i=AA 2048w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_1199,h_799,c_scale\u002Ff_webp,q_auto\u002Fv1792699527\u002Fimages\u002FTIKR.com_JNJ-Johnson-Johnson-Total-Revenues-Change-YoY_143848db573\u002FTIKR.com_JNJ-Johnson-Johnson-Total-Revenues-Change-YoY_143848db573.webp?_i=AA 1199w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_1400,h_933,c_scale\u002Ff_webp,q_auto\u002Fv1792699527\u002Fimages\u002FTIKR.com_JNJ-Johnson-Johnson-Total-Revenues-Change-YoY_143848db573\u002FTIKR.com_JNJ-Johnson-Johnson-Total-Revenues-Change-YoY_143848db573.webp?_i=AA 1400w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_299,h_199,c_scale\u002Ff_webp,q_auto\u002Fv1792699527\u002Fimages\u002FTIKR.com_JNJ-Johnson-Johnson-Total-Revenues-Change-YoY_143848db573\u002FTIKR.com_JNJ-Johnson-Johnson-Total-Revenues-Change-YoY_143848db573.webp?_i=AA 299w\" sizes=\"auto, (max-width: 3026px) 100vw, 3026px\" \u002F>\u003Cfigcaption class=\"wp-element-caption\">존슨앤드존슨 (JNJ): 매출 성장률 (%) 대 애보트, 보스턴 사이언티픽, 메드트로닉, 분기별, 2024년 3분기–2026년 3분기 (\u003Cstrong>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\">TIKR\u003C\u002Fa>\u003C\u002Fstrong>)\u003C\u002Ffigcaption>\u003C\u002Ffigure>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>보스턴 사이언티픽 (BSX)\u003C\u002Fstrong>이 이 그룹에서 속도를 내왔으며, 존슨앤드존슨의 절제 기술 추진은 그 격차를 좁혀야 합니다.\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>TIKR는 존슨앤드존슨에 대해 23명의 애널리스트를 추적합니다. 몇 명이 \"매수\"라고 말할까요?\u003C\u002Fstrong>\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">월스트리트의 매출 및 수익 예측과 함께, 존슨앤드존슨에 대한 매수, 보유, 매도 등급의 전체 분석을 한곳에서 확인하세요. 500,000명 이상의 투자자가 TIKR을 사용하여 이와 같은 주식을 조사합니다. \u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\">존슨앤드존슨의 애널리스트 등급 보기\u003C\u002Fa>\u003C\u002Fp>\n\n\n\n\u003Ch2 class=\"wp-block-heading\">제약사 수준의 가격을 지불 중\u003C\u002Fh2>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">$269에서 존슨앤드존슨은 선행 PER 23.2배로 거래되며, 18.9배인 AbbVie보다 높습니다. 평균적인 월스트리트 목표가 $279는 4% 미만의 상승 여력을 시사합니다.\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">이 프리미엄은 합의치와 조화시키기 어렵습니다. 합의치는 향후 2년간 EPS가 연간 3.8%만 성장할 것으로 예상합니다. 재무제표는 순부채 대 EBITDA 비율 0.82배로 건전하므로, 투자자들은 안전성과 의약품 파이프라인에 대한 대가를 지불하고 있습니다.\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">정형외과는 또 다른 미결제 문제입니다. DePuy Synthes의 고관절 및 무릎 부문을 약 $200억 달러에 \u003Cstrong>아폴로 글로벌 매니지먼트 (\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fstock\u002Fabout?fid=1&ref=meufz8&cid=18833&tid=1762730483\">APO\u003C\u002Fa>)\u003C\u002Fstrong>에 매각하기 위한 협상이 9월에 보도되었지만, 존슨앤드존슨은 이제 분사 쪽으로 기울고 있습니다.\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">이 프리미엄은 존슨앤드존슨의 과거와 비교할 때 더욱 두드러져 보입니다...\u003C\u002Fp>\n\n\n\n\u003Cfigure class=\"wp-block-image size-full\">\u003Cimg width=\"3026\" height=\"2017\" data-public-id=\"images\u002FTIKR.com_Johnson-Johnson-JNJ-NTM-Price-_-Normalized-Earnings-P_E_143847115d2\u002FTIKR.com_Johnson-Johnson-JNJ-NTM-Price-_-Normalized-Earnings-P_E_143847115d2.webp\" loading=\"lazy\" decoding=\"async\" src=\"https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_3026,h_2017,c_scale\u002Ff_webp,q_auto\u002Fv1792699433\u002Fimages\u002FTIKR.com_Johnson-Johnson-JNJ-NTM-Price-_-Normalized-Earnings-P_E_143847115d2\u002FTIKR.com_Johnson-Johnson-JNJ-NTM-Price-_-Normalized-Earnings-P_E_143847115d2.webp?_i=AA\" alt=\"\" class=\"wp-post-143738 wp-image-143847\" data-format=\"webp\" data-transformations=\"f_webp,q_auto\" data-version=\"1792699433\" data-seo=\"1\" srcset=\"https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Ff_webp,q_auto\u002Fv1792699433\u002Fimages\u002FTIKR.com_Johnson-Johnson-JNJ-NTM-Price-_-Normalized-Earnings-P_E_143847115d2\u002FTIKR.com_Johnson-Johnson-JNJ-NTM-Price-_-Normalized-Earnings-P_E_143847115d2.webp?_i=AA 3026w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_1536,h_1024,c_scale\u002Ff_webp,q_auto\u002Fv1792699433\u002Fimages\u002FTIKR.com_Johnson-Johnson-JNJ-NTM-Price-_-Normalized-Earnings-P_E_143847115d2\u002FTIKR.com_Johnson-Johnson-JNJ-NTM-Price-_-Normalized-Earnings-P_E_143847115d2.webp?_i=AA 1536w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1792699433\u002Fimages\u002FTIKR.com_Johnson-Johnson-JNJ-NTM-Price-_-Normalized-Earnings-P_E_143847115d2\u002FTIKR.com_Johnson-Johnson-JNJ-NTM-Price-_-Normalized-Earnings-P_E_143847115d2.webp?_i=AA 600w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_767,h_511,c_scale\u002Ff_webp,q_auto\u002Fv1792699433\u002Fimages\u002FTIKR.com_Johnson-Johnson-JNJ-NTM-Price-_-Normalized-Earnings-P_E_143847115d2\u002FTIKR.com_Johnson-Johnson-JNJ-NTM-Price-_-Normalized-Earnings-P_E_143847115d2.webp?_i=AA 767w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_2048,h_1365,c_scale\u002Ff_webp,q_auto\u002Fv1792699433\u002Fimages\u002FTIKR.com_Johnson-Johnson-JNJ-NTM-Price-_-Normalized-Earnings-P_E_143847115d2\u002FTIKR.com_Johnson-Johnson-JNJ-NTM-Price-_-Normalized-Earnings-P_E_143847115d2.webp?_i=AA 2048w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_1199,h_799,c_scale\u002Ff_webp,q_auto\u002Fv1792699433\u002Fimages\u002FTIKR.com_Johnson-Johnson-JNJ-NTM-Price-_-Normalized-Earnings-P_E_143847115d2\u002FTIKR.com_Johnson-Johnson-JNJ-NTM-Price-_-Normalized-Earnings-P_E_143847115d2.webp?_i=AA 1199w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_299,h_199,c_scale\u002Ff_webp,q_auto\u002Fv1792699433\u002Fimages\u002FTIKR.com_Johnson-Johnson-JNJ-NTM-Price-_-Normalized-Earnings-P_E_143847115d2\u002FTIKR.com_Johnson-Johnson-JNJ-NTM-Price-_-Normalized-Earnings-P_E_143847115d2.webp?_i=AA 299w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_1400,h_933,c_scale\u002Ff_webp,q_auto\u002Fv1792699433\u002Fimages\u002FTIKR.com_Johnson-Johnson-JNJ-NTM-Price-_-Normalized-Earnings-P_E_143847115d2\u002FTIKR.com_Johnson-Johnson-JNJ-NTM-Price-_-Normalized-Earnings-P_E_143847115d2.webp?_i=AA 1400w\" sizes=\"auto, (max-width: 3026px) 100vw, 3026px\" \u002F>\u003Cfigcaption class=\"wp-element-caption\">존슨앤드존슨 (JNJ): 선행 (NTM) PER, 지난 5년간 (\u003Cstrong>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\">TIKR\u003C\u002Fa>\u003C\u002Fstrong>)\u003C\u002Ffigcaption>\u003C\u002Ffigure>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">PER은 5년 범위의 상단 근처에 위치합니다.\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">제 생각: 목요일의 급등은 저에게는 섹터 로테이션으로 보이며, 메드테크에 대해 많은 것을 말해주지 않습니다. 전기생리학 데이터는 마음에 들지만, 23배 PER은 의료기기 성장률이 다시 5% 이상으로 돌아오는 것을 필요로 하며, DePuy 부문의 깔끔한 분리가 가장 큰 도움이 될 것입니다.\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">1월의 4분기 실적은 2027년 예측과, 이상적으로는 정형외과에 대한 확고한 결정을 가져올 것입니다. 그때가 메드테크의 하락세가 바닥을 쳤는지 판단할 순간입니다.\u003C\u002Fp>\n\n\n\n\u003Ch2 id=\"h-so-what-is-johnson-amp-johnson-stock-actually-worth\" class=\"wp-block-heading\">\u003Cstrong>그렇다면 존슨앤드존슨 주식의 실제 가치는 얼마일까요?\u003C\u002Fstrong>\u003C\u002Fh2>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">TIKR를 사용하면 어떤 주식의 미래 가격도 1분 안에 예측할 수 있습니다. TIKR의 가치 평가 모델에 몇 가지 가정을 입력하기만 하면 존슨앤드존슨이 얼마나 가치가 있을지 확인할 수 있습니다. 월스트리트 합의치 예측에서 시작하거나, 입력값을 조정하여 여러분 자신의 사업 전망을 반영하세요. 무료로 사용할 수 있습니다. \u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\">\u003Cstrong>JNJ 무료 가치 평가하기\u003C\u002Fstrong>\u003C\u002Fa>.\u003C\u002Fp>\n\n\n\n\u003Ch3 id=\"h-disclaimer\" class=\"wp-block-heading\">\u003Cstrong>면책 조항:\u003C\u002Fstrong>\u003C\u002Fh3>\n\n\n\n\u003Cp class=\"wp-block-paragraph\" id=\"h-\">\u003Cem>TIKR의 기사는 TIKR나 저희 콘텐츠 팀의 투자 또는 재정 조언으로 의도되거나, 특정 주식을 매수 또는 매도하라는 권고 사항이 아님을 유의해 주십시오. 저희는 TIKR Terminal의 투자 데이터와 애널리스트 예측을 바탕으로 콘텐츠를 작성합니다. 저희 분석에는 최근 기업 뉴스나 중요한 업데이트가 포함되지 않을 수 있습니다. TIKR는 언급된 주식에 어떠한 포지션도 보유하고 있지 않습니다. 읽어주셔서 감사합니다, 행운 있는 투자 되세요!\u003C\u002Fem>\u003C\u002Fp>",913,"ko","\u002Fblog\u002Fjohnson-johnson-jumps-4-4-as-varipulse-pro-hits-100-procedural-success","johnson-johnson-jumps-4-4-as-varipulse-pro-hits-100-procedural-success","images\u002FJNJ-stock_1437491291e\u002FJNJ-stock_1437491291e","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1792696575\u002Fimages\u002FJNJ-stock_1437491291e\u002FJNJ-stock_1437491291e.png?_i=AA",{"altText":165,"imageCredit":166},"Johnson & Johnson Jumps 4.4% as VARIPULSE Pro Hits 100% Procedural Success","AndreyPopov from Getty Images and Aris Leoven from corelens via Canva",{"name":168,"slug":169,"role":170,"roleTitle":171,"biography":171,"avatar":171,"socialMediaLinks":172},"Rexielyn Diaz","rexietikr","author","",[],{"name":174,"slug":175,"role":176,"roleTitle":171,"biography":171,"avatar":171,"socialMediaLinks":177},"David Hanson","davidtikr","editor",[],[179],{"name":180,"slug":181,"uri":182,"description":171,"postsCount":183},"일반 투자","general-investing","\u002Fblog\u002Fcategory\u002Fgeneral-investing",0,[],{"title":165,"metaDesc":186,"opengraphDescription":186,"twitterTitle":165,"twitterDescription":186},"Johnson & Johnson jumped 4.4%, erasing its post-earnings drop as VARIPULSE Pro data gave MedTech a rare win.",{"title":188,"description":189,"twitterTitle":188,"twitterDescription":189,"author":168,"articlePublisher":190,"articlePublishedTime":154,"articleModifiedTime":155,"twitterLabel1":191,"twitterData1":192,"ogTitle":188,"ogDescription":189,"ogUrl":160,"ogImage":163,"ogImageWidth":193,"ogImageHeight":194,"ogImageSecureUrl":163,"ogImageAlt":165,"twitterImage":163},"Johnson & Johnson Jumps 4.4% as VARIPULSE Pro Hits 100% Procedural Success","Johnson & Johnson jumped 4.4%, erasing its post-earnings drop as VARIPULSE Pro data gave MedTech a rare win.","TIKR.com","예상 독서 시간","5 minutes",1200,630,[196,213,228,243,258],{"id":183,"title":197,"date":198,"excerpt":199,"wordCount":200,"uri":201,"slug":202,"cloudinaryAssetId":203,"featuredImageOriginalUrl":204,"featuredImageMetadata":205,"author":206,"categories":210,"relatedPosts":212},"JPMorgan, DraftKings 목표주가 하향 조정. 여전히 46% 상승 여력 전망","2026-10-23 13:30:00","월가가 목표가를 계속 낮추면서도 계속 '매수'를 외치고 있습니다",826,"\u002Fblog\u002Fjpmorgan-cut-its-draftkings-target-it-still-sees-46-upside","jpmorgan-cut-its-draftkings-target-it-still-sees-46-upside","images\u002FJ.P.-Morgan\u002FJ.P.-Morgan","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1792679357\u002Fimages\u002FJ.P.-Morgan\u002FJ.P.-Morgan.png?_i=AA",{"altText":197},{"name":207,"slug":208,"role":170,"roleTitle":171,"biography":171,"avatar":171,"socialMediaLinks":209},"Roxanna Maglangit","roxtikr",[],[211],{"name":180,"slug":181,"uri":182,"description":171,"postsCount":183},[],{"id":183,"title":214,"date":215,"excerpt":216,"wordCount":217,"uri":218,"slug":219,"cloudinaryAssetId":220,"featuredImageOriginalUrl":221,"featuredImageMetadata":222,"author":223,"categories":225,"relatedPosts":227},"UnitedHealth, Optum Health 이익 7억 3,500만 달러로 급증하며 실적 발표 후 9% 상승","2026-10-23 13:20:00","UnitedHealth는 EPS가 61% 급등하고 세 번째로 가이던스를 상향 조정한 후 425달러까지 상승했지만, 매출은 계속 축소되고 있습니다.",914,"\u002Fblog\u002Funitedhealth-climbs-9-since-earnings-as-optum-health-profit-surges-to-735-million","unitedhealth-climbs-9-since-earnings-as-optum-health-profit-surges-to-735-million","images\u002FUNH-stock_14374868532\u002FUNH-stock_14374868532","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1792696335\u002Fimages\u002FUNH-stock_14374868532\u002FUNH-stock_14374868532.png?_i=AA",{"altText":214},{"name":168,"slug":169,"role":170,"roleTitle":171,"biography":171,"avatar":171,"socialMediaLinks":224},[],[226],{"name":180,"slug":181,"uri":182,"description":171,"postsCount":183},[],{"id":183,"title":229,"date":230,"excerpt":231,"wordCount":232,"uri":233,"slug":234,"cloudinaryAssetId":235,"featuredImageOriginalUrl":236,"featuredImageMetadata":237,"author":238,"categories":240,"relatedPosts":242},"AMD 11% 하락, 인텔 1주일 만에 10% 하락… AI 우려에 칩주 하락: \"너무 빨리 너무 크게\"","2026-10-23 13:17:00","두 번의 추한 날들, 그리고 AMD로부터 한마디도 없네요.",715,"\u002Fblog\u002Famd-sinks-11-intel-10-in-a-week-as-ai-fears-hit-chips-too-big-too-fast","amd-sinks-11-intel-10-in-a-week-as-ai-fears-hit-chips-too-big-too-fast","images\u002FAMD_1432925b014\u002FAMD_1432925b014","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1792679128\u002Fimages\u002FAMD_1432925b014\u002FAMD_1432925b014.png?_i=AA",{"altText":229},{"name":207,"slug":208,"role":170,"roleTitle":171,"biography":171,"avatar":171,"socialMediaLinks":239},[],[241],{"name":180,"slug":181,"uri":182,"description":171,"postsCount":183},[],{"id":183,"title":244,"date":245,"excerpt":246,"wordCount":247,"uri":248,"slug":249,"cloudinaryAssetId":250,"featuredImageOriginalUrl":251,"featuredImageMetadata":252,"author":253,"categories":255,"relatedPosts":257},"Chevron, Hess Midstream 매각 및 Aphrodite 가스 개발 추진으로 2026년까지 49.5% 상승","2026-10-23 13:10:00","체브론이 3분기로 향하며 기록적인 고점 근처에서 거래되고 있습니다. 100달러의 유가가 30억~40억 달러의 중간 유통 손실과 맞물리는 상황입니다.",980,"\u002Fblog\u002Fchevron-gains-49-5-in-2026-as-it-exits-hess-midstream-and-advances-aphrodite-gas","chevron-gains-49-5-in-2026-as-it-exits-hess-midstream-and-advances-aphrodite-gas","images\u002FCVX-stock_14374763728\u002FCVX-stock_14374763728","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1792696158\u002Fimages\u002FCVX-stock_14374763728\u002FCVX-stock_14374763728.png?_i=AA",{"altText":244},{"name":168,"slug":169,"role":170,"roleTitle":171,"biography":171,"avatar":171,"socialMediaLinks":254},[],[256],{"name":180,"slug":181,"uri":182,"description":171,"postsCount":183},[],{"id":183,"title":259,"date":260,"excerpt":261,"wordCount":247,"uri":262,"slug":263,"cloudinaryAssetId":264,"featuredImageOriginalUrl":265,"featuredImageMetadata":266,"author":267,"categories":269,"relatedPosts":271},"머크 주가 하락, 키트루다 백신 병용 요법이 흑색종 재발 위험 42% 감소","2026-10-23 13:00:00","Merck의 Moderna와의 흑색종 백신이 재발 또는 사망 위험을 42% 감소시켰음에도, 주가는 3분기 실적 발표를 앞두고 하락했습니다.","\u002Fblog\u002Fmerck-slips-as-keytruda-vaccine-combo-cuts-melanoma-recurrence-risk-by-42","merck-slips-as-keytruda-vaccine-combo-cuts-melanoma-recurrence-risk-by-42","images\u002FMRK-stock_1437469bc50\u002FMRK-stock_1437469bc50","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1792695966\u002Fimages\u002FMRK-stock_1437469bc50\u002FMRK-stock_1437469bc50.png?_i=AA",{"altText":259},{"name":168,"slug":169,"role":170,"roleTitle":171,"biography":171,"avatar":171,"socialMediaLinks":268},[],[270],{"name":180,"slug":181,"uri":182,"description":171,"postsCount":183},[],[273,293,309,324,339],{"id":183,"title":274,"date":275,"excerpt":276,"wordCount":277,"uri":278,"slug":279,"cloudinaryAssetId":280,"featuredImageOriginalUrl":281,"featuredImageMetadata":282,"author":283,"categories":287,"relatedPosts":292},"IREN 주식, 스페인 캠퍼스 랠리 이후 하루 만에 8% 하락. 월스트리트 목표가가 시사하는 바는 다음과 같습니다","2026-10-23 07:20:00","IREN은 네오클라우드 주식들이 부채 우려로 매도되면서 스페인 캠퍼스 상승분을 단 하루 만에 되돌렸습니다. 300MW 바다호스 라이선스는 용량을 추가하지만, IREN은 아직 데이터센터를 담보로 한 대출을 마무리하지 못했습니다. 애널리스트들의 12개월 목표가가 시사하는 바는 다음과 같습니다.",908,"\u002Fblog\u002Firen-stock-fell-8-in-a-day-after-its-spain-campus-rally-heres-what-wall-streets-targets-imply","iren-stock-fell-8-in-a-day-after-its-spain-campus-rally-heres-what-wall-streets-targets-imply","images\u002F18_14404989fa4\u002F18_14404989fa4","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1792717505\u002Fimages\u002F18_14404989fa4\u002F18_14404989fa4.png?_i=AA",{"altText":274},{"name":284,"slug":285,"role":170,"roleTitle":171,"biography":171,"avatar":171,"socialMediaLinks":286},"Wiltone Asuncion","wiltonetikr",[],[288],{"name":289,"slug":290,"uri":291,"description":171,"postsCount":183},"주식 리뷰","reviews","\u002Fblog\u002Fcategory\u002Freviews",[],{"id":183,"title":294,"date":295,"excerpt":296,"wordCount":297,"uri":298,"slug":299,"cloudinaryAssetId":300,"featuredImageOriginalUrl":301,"featuredImageMetadata":302,"author":304,"categories":306,"relatedPosts":308},"Hims & Hers 주가, 최대 규모 남성 건강 제품 출시 이후 거의 움직이지 않아. 11월 9일이 보여준 것은 다음과 같다","2026-10-23 07:15:00","Hims & Hers는 10월 21일에 주사용 및 경구용 테스토스테론을 출시했으며, 그 이후 주가는 거의 움직이지 않았습니다. 경영진은 8월에 이 출시를 약속했으며, 테스토스테론이 1억 달러의 연간화된 페이스(run-rate)에 도달할 것으로 예상합니다. 12월 31일 DEA 마감일과 11월 9일 실적 발표가 다음 시험대가 될 것입니다.",977,"\u002Fblog\u002Fhims-hers-stock-has-barely-moved-since-its-biggest-mens-health-launch-heres-what-november-9-has-to-show","hims-hers-stock-has-barely-moved-since-its-biggest-mens-health-launch-heres-what-november-9-has-to-show","images\u002F17_144048ee756\u002F17_144048ee756","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1792717512\u002Fimages\u002F17_144048ee756\u002F17_144048ee756.png?_i=AA",{"altText":303},"Hims & Hers 주가, 최대 규모 남성 건강 제품 출시 이후 거의 움직이지 않아. 11월 9일이 보여준 것은 다음과 같다",{"name":284,"slug":285,"role":170,"roleTitle":171,"biography":171,"avatar":171,"socialMediaLinks":305},[],[307],{"name":289,"slug":290,"uri":291,"description":171,"postsCount":183},[],{"id":183,"title":310,"date":311,"excerpt":312,"wordCount":313,"uri":314,"slug":315,"cloudinaryAssetId":316,"featuredImageOriginalUrl":317,"featuredImageMetadata":318,"author":319,"categories":321,"relatedPosts":323},"브로드컴 주가 4% 하락, 반도체주 하락세 속 10년 만의 VMware 인수 후 며칠 지나... 월가의 목표가가 말하는 것","2026-10-23 07:10:00","브로드컴은 10월 22일 반도체주가 하락에 따라 4.31% 하락했으며, 이는 일본에서 첫 10년간 VM웨어 계약을 체결한 지 며칠 지나지 않아 발생한 일입니다. 이익 예측은 계속 상승하고 있지만, 주가는 2월 수준보다 낮게 거래되고 있습니다.",903,"\u002Fblog\u002Fbroadcom-stock-fell-4-as-chip-stocks-slid-days-after-a-10-year-vmware-deal-heres-what-wall-streets-targets-say","broadcom-stock-fell-4-as-chip-stocks-slid-days-after-a-10-year-vmware-deal-heres-what-wall-streets-targets-say","images\u002F16-1_14404727574\u002F16-1_14404727574","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1792717515\u002Fimages\u002F16-1_14404727574\u002F16-1_14404727574.png?_i=AA",{"altText":310},{"name":284,"slug":285,"role":170,"roleTitle":171,"biography":171,"avatar":171,"socialMediaLinks":320},[],[322],{"name":289,"slug":290,"uri":291,"description":171,"postsCount":183},[],{"id":183,"title":325,"date":326,"excerpt":327,"wordCount":328,"uri":329,"slug":330,"cloudinaryAssetId":331,"featuredImageOriginalUrl":332,"featuredImageMetadata":333,"author":334,"categories":336,"relatedPosts":338},"Nebius 주식이 35억 달러 Citi 시설 발표 당일 7% 하락했습니다. AI 칩 부족이 얼마나 지속될지에 대한 CEO의 발언은 다음과 같습니다.","2026-10-23 07:00:00","Nebius는 10월 22일 35억 달러 규모의 364일 만기 Citi 시설을 발표한 날 7.23% 하락했으며, CoreWeave와 IREN은 2026년 최저치로 떨어졌습니다. 9월에 해당 회사의 CEO는 AI 컴퓨팅 공급이 수요를 따라잡는 대략적인 시기를 언급했습니다. 그 시기는 새로운 거래의 투자 회수 기간과 가깝습니다.",784,"\u002Fblog\u002Fnebius-stock-fell-7-the-day-it-announced-a-3-5-billion-citi-facility-heres-what-its-ceo-said-about-how-long-the-ai-chip-shortage-lasts","nebius-stock-fell-7-the-day-it-announced-a-3-5-billion-citi-facility-heres-what-its-ceo-said-about-how-long-the-ai-chip-shortage-lasts","images\u002F14-1_144045ee128\u002F14-1_144045ee128","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1792717438\u002Fimages\u002F14-1_144045ee128\u002F14-1_144045ee128.png?_i=AA",{"altText":325},{"name":284,"slug":285,"role":170,"roleTitle":171,"biography":171,"avatar":171,"socialMediaLinks":335},[],[337],{"name":289,"slug":290,"uri":291,"description":171,"postsCount":183},[],{"id":183,"title":340,"date":341,"excerpt":342,"wordCount":343,"uri":344,"slug":345,"cloudinaryAssetId":346,"featuredImageOriginalUrl":347,"featuredImageMetadata":348,"author":349,"categories":351,"relatedPosts":353},"머크, 유럽에서 키트루다의 방광암 적응증 확대 승인. ESMO 데이터에서 보여야 할 것은 다음과 같습니다","2026-10-22 21:00:00","유럽이 키트루다와 패드세브 병용 요법을 시스플라틴 적격성과 무관하게 방광암 환자로 확대했습니다. 3일 후, ESMO에서 머크의 암 백신이 연구 책임자가 설정한 기준을 통과하는지 여부가 공개됩니다.",836,"\u002Fblog\u002Fmerck-won-a-wider-eu-bladder-cancer-label-for-keytruda-heres-what-its-esmo-data-needs-to-show","merck-won-a-wider-eu-bladder-cancer-label-for-keytruda-heres-what-its-esmo-data-needs-to-show","images\u002F13-7_1439568ebea\u002F13-7_1439568ebea","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1792700551\u002Fimages\u002F13-7_1439568ebea\u002F13-7_1439568ebea.png?_i=AA",{"altText":340},{"name":284,"slug":285,"role":170,"roleTitle":171,"biography":171,"avatar":171,"socialMediaLinks":350},[],[352],{"name":289,"slug":290,"uri":291,"description":171,"postsCount":183},[]]